Simvastatin Patent Expiration

Simvastatin was first introduced by Organon Llc A Sub Of Organon And Co in its drug Zocor on Dec 23, 1991. Other drugs containing Simvastatin are Flolipid, Simvastatin. 19 different companies have introduced drugs containing Simvastatin.


Simvastatin Patents

Given below is the list of patents protecting Simvastatin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Flolipid US9597289 Liquid oral simvastatin compositions Feb 23, 2030 Salerno Pharms
Flolipid US10300041 Liquid oral simvastatin compositions Apr 26, 2027 Salerno Pharms



Simvastatin's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Simvastatin Generic API Manufacturers

Several generic applications have been filed for Simvastatin. The first generic version for Simvastatin was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Jun 23, 2006. And the latest generic version is by Yiling Pharmaceutical Ltd and was approved on Nov 27, 2024.

Given below is the list of companies who have filed for Simvastatin generic, along with the locations of their manufacturing plants worldwide.